3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
17
Colorectal Neoplasms
15
Colonic Neoplasms
8
Carcinoma, Non-Small-Cell Lung
5
Brain Neoplasms
5
Skin Neoplasms
4
Rectal Neoplasms
4
Neoplasms
4
Lung Neoplasms
3
Neoplasm Metastasis
2
Gastrointestinal Neoplasms
2
Digestive System Neoplasms
2
Thyroid Neoplasms
1
Solid Tumors
1
Skin Diseases
1
Rectal Diseases
1
Pancreatic Neoplasms
1
Neurofibromatosis 1
1
Lymphatic Metastasis
1
Leukemia, Hairy Cell
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Hereditary Sensory and Autonomic Neuropathies
1
Gastrointestinal Diseases
1
Disease Progression
1
Digestive System Diseases
1
Colonic Diseases
1
Biliary Tract Neoplasms
1
Interventions
Temozolomide
15
Radiotherapy
10
Radiation
8
Magnetic Resonance Spectroscopy
7
pembrolizumab
5
Specimen Handling
5
Ipilimumab
3
atezolizumab
2
Photons
2
Nivolumab
2
Biopsy
2
veliparib
1
selinexor
1
sargramostim
1
plerixafor
1
peposertib
1
pazopanib
1
navtemadlin; 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid
1
montanide ISA 51
1
liposomal doxorubicin
1
gosha-jinki-gan
1
fluorodopa F 18
1
ferric pyrophosphate
1
efineptakin alfa
1
cemiplimab
1
cabozantinib
1
balstilimab
1
abexinostat
1
X-Rays
1
Vorinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gliosarcoma
×
encorafenib
×
1 year
×
Clear all
No trials found.